217 related articles for article (PubMed ID: 32257985)
1. Essential Metabolic Routes as a Way to ESKAPE From Antibiotic Resistance.
Barra ALC; Dantas LOC; Morão LG; Gutierrez RF; Polikarpov I; Wrenger C; Nascimento AS
Front Public Health; 2020; 8():26. PubMed ID: 32257985
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review.
Zhen X; Lundborg CS; Sun X; Hu X; Dong H
Antimicrob Resist Infect Control; 2019; 8():137. PubMed ID: 31417673
[TBL] [Abstract][Full Text] [Related]
3. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Resistance in ESKAPE Pathogens.
De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health.
Denissen J; Reyneke B; Waso-Reyneke M; Havenga B; Barnard T; Khan S; Khan W
Int J Hyg Environ Health; 2022 Jul; 244():114006. PubMed ID: 35841823
[TBL] [Abstract][Full Text] [Related]
6. Alternatives for the treatment of infections caused by ESKAPE pathogens.
da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
[TBL] [Abstract][Full Text] [Related]
7. Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
Sivinski J; Ambrose AJ; Panfilenko I; Zerio CJ; Machulis JM; Mollasalehi N; Kaneko LK; Stevens M; Ray AM; Park Y; Wu C; Hoang QQ; Johnson SM; Chapman E
mBio; 2021 Jan; 12(1):. PubMed ID: 33436430
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance of ESKAPE group-microorganisms in health institutions from Hermosillo and Ciudad Obregón, Sonora, México.
Álvarez-Ainza ML; Fong-Coronado PA; Ruiz-Bustos E; Castillón-Campaña LG; Quintero-Reyes IE; Duarte-Zambrano LA; Bolado-Martínez E
Front Cell Infect Microbiol; 2024; 14():1348093. PubMed ID: 38516533
[TBL] [Abstract][Full Text] [Related]
9. ESKAPE in China: epidemiology and characteristics of antibiotic resistance.
Luo Q; Lu P; Chen Y; Shen P; Zheng B; Ji J; Ying C; Liu Z; Xiao Y
Emerg Microbes Infect; 2024 Dec; 13(1):2317915. PubMed ID: 38356197
[TBL] [Abstract][Full Text] [Related]
10. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.
Saha U; Gondi R; Patil A; Saroj SD
Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207
[TBL] [Abstract][Full Text] [Related]
11. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
[TBL] [Abstract][Full Text] [Related]
12. 1-deoxy-D-xylulose-5-phosphate synthase from Pseudomonas aeruginosa and Klebsiella pneumoniae reveals conformational changes upon cofactor binding.
Hamid R; Adam S; Lacour A; Monjas L; Köhnke J; Hirsch AKH
J Biol Chem; 2023 Sep; 299(9):105152. PubMed ID: 37567475
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon.
Mouanga-Ndzime Y; Onanga R; Longo-Pendy NM; Bignoumba M; Bisseye C
Antimicrob Resist Infect Control; 2023 May; 12(1):47. PubMed ID: 37173760
[TBL] [Abstract][Full Text] [Related]
14. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.
Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB
Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722
[TBL] [Abstract][Full Text] [Related]
15. Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains.
Warawa JM; Duan X; Anderson CD; Sotsky JB; Cramer DE; Pfeffer TL; Guo H; Adcock S; Lepak AJ; Andes DR; Slone SA; Stromberg AJ; Gabbard JD; Severson WE; Lawrenz MB
Microbiol Spectr; 2022 Oct; 10(5):e0269322. PubMed ID: 36094219
[TBL] [Abstract][Full Text] [Related]
16. Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.
Vrancianu CO; Gheorghe I; Dobre EG; Barbu IC; Cristian RE; Popa M; Lee SH; Limban C; Vlad IM; Chifiriuc MC
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198306
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the ESKAPE pathogens.
Pendleton JN; Gorman SP; Gilmore BF
Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
[TBL] [Abstract][Full Text] [Related]
18. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.
Founou RC; Founou LL; Allam M; Ismail A; Essack SY
Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772
[TBL] [Abstract][Full Text] [Related]
19. Multi-drug resistant ESKAPE pathogens and the uses of plants as their antimicrobial agents.
Idris FN; Nadzir MM
Arch Microbiol; 2023 Mar; 205(4):115. PubMed ID: 36917278
[TBL] [Abstract][Full Text] [Related]
20. Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens.
Das S; Bombaywala S; Srivastava S; Kapley A; Dhodapkar R; Dafale NA
Environ Sci Pollut Res Int; 2022 Jun; 29(27):40507-40519. PubMed ID: 35349073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]